Telefonica Partners with Vithas and Francisco de Vitoria University for Quantum Computing in Cancer Drug Research
Telefonica collaborates with Fundacion Vithas and Francisco de Vitoria University to apply quantum computing in cancer drug development. The project will be showcased at MWC26 Barcelona. It employs a hybrid model of classical and quantum computing to design molecules targeting mutations linked to malignant tumors, significantly reducing research times compared to traditional methods.
Theia Market Signal Identification - AI Assisted
Telefonica is collaborating with Fundacion Vithas and Francisco de Vitoria University to utilize quantum computing for cancer drug development. This project, to be discussed at MWC26 Barcelona, employs a hybrid model of classical and quantum computing to create molecules that inhibit mutations responsible for various malignant tumors.
The use of quantum computing allows for a more efficient exploration of chemical combinations, reducing research times that would typically span years with conventional computing methods. The initiative reflects the practical application of quantum computing in healthcare and other sectors.
Comments